HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study.

Abstract
Protein Tyrosine Phosphatase H1/Protein Tyrosine Phosphatase Non receptor Type 3 (PTPH1/PTPN3) is upregulated and/or mutated in glioma, ovarian, gastric, and colorectal cancers. Previous studies have documented that PTPH1-associated breast cancers exhibit enhanced sensitivity to tamoxifen and tyrosine kinase inhibitors through dephosphorylation of ER and epidermal growth factor receptor, respectively. Owing to the key role that PTPH1 plays as a biomarker in predicting the response of chemotherapeutic drugs and lack of studies on Indian breast cancer patients, the present study investigated PTPH1 protein expression and its relationship to clinical features, ER/PR/HER2/neu statuses, and methylation of promoter in breast cancer tissues (n = 67) among Indian population by immunohistochemistry and methylation specific polymerase chain reaction. PTPH1 expression was upregulated in 58.21% (39/67) and downregulated in the rest of tumor specimens, and it correlated with ER, PR, and HER2/neu statuses with p values of <0.0001, 0.0113, and 0.0448, respectively. Additionally, we found that the 2 kb region upstream of PTPH1 gene harbored CpG sites within, and was ubiquitously methylated in breast cancer (n = 13), colon cancer tissue (n = 1), uterine cancer tissue (n = 1), normal breast tissue (n = 1) in addition to Hela and MCF7 cell lines. In conclusion, our data showed a strong correlation of the PTPH1 status with the ER and ubiquitous nature of PTPH1 promoter methylation at specific CpG sites irrespective of cancer types and protein expression. Our findings underscore the clinical relevance of PTPH1 expression in Indian patients and warrant additional studies to explore the importance of ubiquitously methylated promoter at specific CpG sites in upstream of the PTPH1 gene.
AuthorsThejaswini Venkatesh, Abhishek Shetty, Shrijeet Chakraborti, Padmanaban S Suresh
JournalJournal of cellular physiology (J Cell Physiol) Vol. 234 Issue 2 Pg. 1071-1079 (02 2019) ISSN: 1097-4652 [Electronic] United States
PMID30189107 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 Wiley Periodicals, Inc.
Chemical References
  • Biomarkers, Tumor
  • Receptors, Estrogen
  • Receptors, Progesterone
  • PTPN3 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 3
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (genetics, metabolism)
  • Breast Neoplasms (enzymology, genetics)
  • CpG Islands
  • DNA Methylation
  • Female
  • HeLa Cells
  • Humans
  • Immunohistochemistry
  • India
  • MCF-7 Cells
  • Middle Aged
  • Polymerase Chain Reaction
  • Predictive Value of Tests
  • Promoter Regions, Genetic
  • Protein Tyrosine Phosphatase, Non-Receptor Type 3 (genetics, metabolism)
  • Receptors, Estrogen (metabolism)
  • Receptors, Progesterone (metabolism)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: